Simultaneous chiral separation and determination of carvedilol and 5′-hydroxyphenyl carvedilol enantiomers from human urine by high performance liquid chromatography coupled with fluorescent detection

A sensitive and specific high performance liquid chromatography coupled with fluorescent detection (HPLC-FL) and tandem mass spectrometry detection (HPLC-MS/MS) methods for separation and determination of carvedilol (CAR) enantiomers and 5′-hydroxyphenyl carvedilol (5′-HCAR) enantiomers has been developed and validated. The analysed compounds were extracted from human urine by solid phase extraction. Good enantioseparation of the studied enantiomers was achieved on CHIRALCEL® OD-RH column using 0.05% trifluoroacetic acid and 0.05% diethylamine in water and acetonitrile in a gradient elution. The mass spectrometric data were acquired using the multiple reaction monitoring mode by positive electrospray ionisation. The method was validated over the concentration range from 25.0 ng mL^?1 to 200 ng mL^?1 for the analysed compounds. The limit of quantification varied from 14.2 ng mL^?1 to 24.2 ng mL^?1. Both the repeatability and inter-day precisions were below 10.0%, and the accuracy varied from ?13.2% to 3.77%. The extraction recoveries ranged from 79.2% to 108%. The present paper reports the method for the simultaneous determination of CAR enantiomers and their metabolite enantiomers (5′-HCAR) in human urine samples. This newly developed method was successfully used to analyse the aforementioned analytes in human urine samples obtained from patients suffering from cardiovascular disease.      

Determination of ofloxacin and gatifloxacin by mixed micelle-mediated cloud point extraction-fluorimetry combined methodology

A cloud point extraction process using mixed micelle of the anionic surfactant sodium dodecyl sulfate (SDS) and the non-ionic surfactant polyoxyethylene(7.5)nonylphenylether (PONPE 7.5) to extract two fluoroquinolone antimicrobial agents, ofloxacin and gatifloxacin, from aqueous media was investigated. The method is based on the mixed micelle-mediated extraction of fluoroquinolones in the presence of NaCl as an inducing agent in phase separation, followed by spectrofluorimetric determination. The effect of different variables such as pH, PONPE7.5 concentration, SDS concentration, NaCl concentration, cloud point temperature, and time was investigated, and optimum conditions were established. At optimum conditions, the rectilinear calibration graphs were obtained in the concentration range of 0.1–150 and 0.1–250 ng mL^?1 for ofloxacin and gatifloxacin, and the limits of detection were 0.04 and 0.06 ng mL^?1, respectively. The proposed procedure was applied successfully for the detection of the investigated drugs in their pharmaceutical dosage forms, in spiked plasma, spiked urine, and urine samples, with good precision and accuracy.     

Development of Immunoaffinity Sample-Purification for GC–MS Analysis of Ractopamine in Swine Tissue

A method combining immunoaffinity chromatography with gas chromatography–mass spectrometry (GC–MS) has been established for determination of ractopamine residues in swine liver and urine. After clean-up on an immunoaffinity chromatography column, GC–MS analysis revealed recovery from blank swine liver and urine fortified at 2.5–20 ng g^?1 (ng mL^?1 for urine), respectively, was 68.2–78.6 and 76.2–83.1%. The limits of detection and quantification were 0.5 ng g^?1 (or ng mL^?1) and 2.0 ng g^?1 (or ng mL^?1), respectively. The procedure was used for analysis of ractopamine residues in samples of swine liver and urine in which the levels were unknown. The amounts detected were 9–216 ng g^?1 (ng mL^?1).     

Application of dispersive liquid–liquid microextraction for the determination of donepezil in urine by HPLC using a core–shell column

A rapid and novel method combining dispersive liquid–liquid microextraction and high-performance liquid chromatography coupled with fluorescence detection was developed for the determination of donepezil in human urine. Parameters affecting extraction efficiency and chromatographic determination, such as the type and volume of the extraction and disperser solvent, pH of sample for dispersive liquid–liquid microextraction, mobile-phase composition, pH, column oven temperature, and flow rate for chromatographic determination, were evaluated and optimized. Using a C₁₈ core–shell column (7.5 × 4.6?mm, 2.7?μm), the determination of donepezil was accomplished within 5?min. Under optimum conditions, developed method was linear in the range of 0.5–25?ng?mL^?1 with the correlation coefficient >0.99. Limit of detection was 0.15?ng?mL^?1. The relative standard deviation at three concentration levels (2, 12.5, and 20?ng?mL^?1) was less than 11% with accuracy in the range of 96.9–102.8%. The results of this study demonstrate that the use of dispersive liquid–liquid microextraction and core–shell column can be considered as a powerful tool for the analysis of donepezil in human urine.     

LC–MS–MS Simultaneous Determination of Paracetamol, Pseudoephedrine and Chlorpheniramine in Human Plasma: Application to a Pharmacokinetic Study

A liquid chromatography–tandem mass spectrometry (LC–MS–MS) method was developed for the simultaneous determination of paracetamol, pseudoephedrine and chlorpheniramine in human plasma. Diphenhydramine was used as the internal standard. Analytes were extracted from alkalized human plasma by liquid–liquid extraction (LLE) using ethyl acetate. After electrospray ionization positive ion fragments were detected in the selected reaction monitoring (SRM) mode with a triple quadrupole tandem mass spectrometer. The method was linear in the concentration range of 20.0–10000.0 ng mL^?1 for paracetamol, 1.0–500.0 ng mL^?1 for pseudoephedrine and 0.1–50.0 ng mL^?1 for chlorpheniramine. The intra- and inter-day precisions were below 14.5% and the bias was between ?7.3 and +2.8% for all analytes. The validated LC–MS–MS method was applied to a pharmacokinetic study in which each healthy Chinese volunteer received a tablet containing 300 mg benorylate, 30 mg pseudoephedrine hydrochloride and 2 mg chlorpheniramine maleate. This is the first assay method described for the simultaneous determination of paracetamol, pseudoephedrine and chlorpheniramine in human plasma samples.     

Selective extraction of catecholamines by packed fiber solid‐phase using composite nanofibers composing of polymeric crown ether with polystyrene

For the first time, electrospun composite nanofibers comprising polymeric crown ether with polystyrene (PCE‐PS) have been used for the selective extraction of catecholamines – dopamine (DA), norepinephrine (NE) and epinephrine (E) – prior to their analysis by high‐performance liquid chromatography–electrochemical detection. Using a minicartridge packed with PCE‐PS composite nanofibers, the target compounds were extracted effectively from urine samples to which diphenylborinic acid 2‐aminoethyl ester was added as a complexing reagent. The extracted catecholamines could be liberated from the fiber by the addition of acetic acid. A good linearity was observed for catecholamines in the range of 2.0–200 ng mL^?1 (NE, E and DA). The detection limits of catecholamines (signal‐to‐noise ratio = 3) were 0.5 ng mL^?1 (NE), 0.2 ng mL^?1 (E) and 0.2 ng mL^?1 (DA), respectively. Under the optimized conditions, the absolute recoveries of the above three catecholamines were 90.6% (NE), 88.5% (E) and 94.5% (DA). The repeatability of extraction performance was from 5.4 to 9.2% (expressed as relative standard deviation). Our results indicate that the proposed method could be used for the determination of NE, E and DA in urine. Copyright © 2014 John Wiley & Sons, Ltd.     

Multi‐residue analysis of eight thioamphetamine designer drugs in human urine by liquid chromatography/tandem mass spectrometry

An analytical procedure for the simultaneous determination in human urine of several thioamphetamine designer drugs (2C‐T and ALEPH series) is reported. The quantitative analysis was performed by liquid chromatography/tandem mass spectrometry and has been fully validated. The mass spectrometer was operated in positive‐ion, selected reaction monitoring (SRM) mode. In order to minimize interferences with matrix components and to preconcentrate target analytes, solid‐phase extraction was introduced in the method as a clean‐up step. The entire method was validated for selectivity, linearity, precision and accuracy. The method turned out to be specific, sensitive, and reliable for the analysis of amphetamine derivatives in urine samples. The calibration curves were linear over the concentration range of 1 to 100 ng mL^?1 for all drugs with correlation coefficients that exceeded 0.996. The lower limits of detection (LODs) and quantification (LOQs) ranged from 1.2 to 4.9 ng mL^?1 and from 3.2 to 9.6 ng mL^?1, respectively. Copyright © 2009 John Wiley & Sons, Ltd.     

Enantioselective Analysis of Amphetamine-Related Designer Drugs in Body Fluids Using Liquid Chromatography and Solid-Phase Derivatization

A method for the enantioselective determination of the amphetamine-derived designer drugs 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxyethylamphetamine (MDE) based on their derivatization with (-)-1-(9-fluorenyl)ethyl chloroformate (FLEC) is described. The proposed procedure entails preconcentration and derivatization of the analytes into C₁₈-packed solid-phase extraction cartridges, chromatographic separation of the diastereomers originated in a C₁₈ column under gradient elution, and UV detection at 265 nm. Compared with the solution derivatization approach the described procedure increased analyte responses by factors of 28–58. The reliability of the method has been tested by analysing plasma and urine samples spiked with the analytes in the 0.015–1.0 μg mL^?1 concentration interval. The proposed conditions provided adequate linearity, and coefficients of variation ranging from 5% to 14% in plasma, and from 3% to 12% in urine. The recoveries of the analytes were of 78%–126% and 78%–128% in plasma and urine, respectively. The limits of detection (LODs) obtained for all the analytes were 5 ng mL^?1 in both biological matrices.     

Validated method for occupational cyclophosphamide monitoring using LC-MS/MS and a Poroshell 120 column

Pharmacy staff and health care workers in hospitals may be exposed to antineoplastic drugs during cancer chemotherapy. Sensitive methods should be used to monitor the occupational exposure in biofluids such as urine. In this study, a sensitive method for cyclophosphamide determination in urine with high recovery was developed and validated for monitoring occupational exposure. Triple liquid-liquid extraction with ethyl acetate/dichloromethane (φ_r= 3:1; 6.0 mL) was applied. Good separation of cyclophosphamide and ifosfamide was achieved in a 9.0 min analysis, using liquid chromatography combined with tandem mass spectrometry (LC-MS/MS). Limit of detection and limit of quantification were 0.07 ng mL^?1 and 0.11 ng mL^?1, respectively. Repeatability (RSD, %) was ≤ 12.74%. Inter-day and inter-analyst precision values (RSD, %) were ≤ 13.94% and 12.59%. Mean recovery for three different concentrations was (101.62 ± 6.05) %. The validation results were fitted for the purpose of routine monitoring of occupational cyclophosphamide exposure in hospital staff.     

Solid phase extraction of trace amounts of Pb(II) in opium, heroin, lipstick, plants and water samples using modified magnetite nanoparticles prior to its atomic absorption determination

A new, simple, fast and reliable solid-phase extraction method has been developed for separation/preconcentration of trace amounts of Pb(II) using dithizone/sodium dodecyl sulfate-immobilized on alumina-coated magnetite nanoparticles, and its determination by flame atomic absorption spectrometry (FAAS) and graphite furnace atomic absorption spectrometry (GFAAS) after eluting with 4.0?mol?L^?1 HNO₃. Optimal experimental conditions including pH, sample volume, eluent concentration and volume, and co-existing ions have been studied and established. Under the optimal experimental conditions, the preconcentration factor, detection limit, linear range and relative standard deviation of Pb(II) using FAAS technique were 280 (for 560?mL of sample solution), 0.28?ng?mL^?1, 1.4?C70?ng?mL^?1 and 4.6% (for 10?ng?mL^?1, n?=?10), respectively. These analytical parameters using GFAAS technique were 300 (for 600?mL of sample solution), 0.002?ng?mL^?1, 0.006?C13.2?ng?mL^?1 and 3.1% (for 5?ng?mL^?1, n?=?10), respectively. The presented procedure was successfully applied for determination of Pb(II) content in opium, heroin, lipstick, plants and water samples.     

Chemical modification of alumina surface by immobilization of 1-((5-nitrofuran-2-yl)methylene)thiosemicarbazide for extractive concentration of silver ions

A column, solid phase extraction (SPE), preconcentration method was developed for determination of silver by using alumina coated with 1-((5-nitrofuran-2-yl)methylene)thiosemicarbazide and determination by flame atomic absorption spectrometry. The separation/preconcentration conditions for the quantitative recovery were investigated. At pH 2, the maximum sorption capacity of Ag⁺ was 7.5?mg?g^?1. The linearity was maintained in the concentration range of 0.02–11.0?µg?mL^?1 in the final solution or 0.14–1.10?×?10^4?ng?mL^?1 in the original solution for silver. The preconcentration factor of 140 and relative standard deviation of ±1.4% was obtained, under optimum conditions. The limit of detection (LOD) was calculated as 0.112?ng?mL^?1, based on 3σ_bl/m (n?=?8) in the original solutions. The proposed method was successfully applied to the determination trace amounts of silver in the environmental samples such as tea, rice and wheat flour, mint, and real water samples.     

Cloud point extraction of aluminum (III) in water samples and determination by electrothermal atomic absorption spectrometry,flame atomic absorption spectrometry and UV-visible spectrophotometry

Cloud point extraction was applied as a preconcentration step for the determination of trace level of Al(III) in water samples with electrothermal atomic absorption spectrometry (ETAAS), flame atomic absorption spectrometry (FAAS) and UV-visible spectrophotometry. The aluminum was extracted as aluminum-Eriochrome Cyanine R (ECR) complex, at pH 6 by micelles of the non-ionic surfactant octylphenoxypolyethoxyethanol (Triton X-114). The investigations showed that the same CPE procedure can be used for different detection techniques. The results obtained from these techniques were evaluated. Under the optimal conditions, limit of detection obtained with ETAAS, FAAS and UV-visible spectrophotometry were 0.03 ng mL^?1, 0.06 µg mL^?1 and 0.01 µg mL^?1, respectively. The accuracy of the procedure was tested by analysing certified reference material. The method was successfully applied to determination of aluminum in water samples and dialysis fluid.     

On-Fiber Derivatization of SPME Extracts of Phenol, Hydroquinone and Catechol with GC-MS Detection

A gas chromatography-mass spectrometry (GC-MS) method for the simultaneous determination of phenol (PHE), hydroquinone (HQ) and catechol (CAT) in urine was developed and validated. The method was based on the acidic hydrolysis of conjugated phenolic compounds and further extraction of analytes using solid-phase microextraction (SPME). Analytes were extracted by submersing the polar polyacrylate coated fiber (85 μm) into urine (adjusted to pH 3.0 with glacial acetic acid) for 20 min with magnetic stirring. The extracted compounds on the fiber were exposed to hexamethyldisilazane reagent in the vapor phase for 20 min to yield the corresponding trimethysililylated derivates. This on-fiber derivatization procedure allowed the formation of more amenable compounds for GC analysis, without adversely affecting the lifetime of the fiber. The MS was operated in the selected ion monitoring mode (SIM). The limits of detection were 0.3 μg mL⁻¹ for PHE, 0.15 μg mL⁻¹ for HQ and 0.02 μg mL⁻¹ for CAT. Inter and intra-assay precisions were also verified (coefficient of variation < 8%) with the use of deuterated internal standards. This method of GC-MS analysis can be readily utilized to monitor PHE and its metabolites (HQ and CAT) in urine samples.     

Determination of three antidepressants in urine using simultaneous derivatization and temperature‐assisted dispersive liquid–liquid microextraction followed by gas chromatography–flame ionization detection

This paper presents a fast and simple method for the extraction, preconcentration and determination of fluvoxamine, nortriptyline and maprotiline in urine using simultaneous derivatization and temperature‐assisted dispersive liquid–liquid microextraction (TA‐DLLME) followed by gas chromatography–flame ionization detection (GC‐FID). An appropriate mixture of dimethylformamide (disperser solvent), 1,1,2,2‐tetrachloroethane (extraction solvent) and acetic anhydride (derivatization agent) was rapidly injected into the heated sample. Then the solution was cooled to room temperature and cloudy solution formed was centrifuged. Finally a portion of the sedimented phase was injected into the GC‐FID. The effect of several factors affecting the performance of the method, including the selection of suitable extraction and disperser solvents and their volumes, volume of derivatization agent, temperature, salt addition, pH and centrifugation time and speed were investigated and optimized. Figures of merit of the proposed method, such as linearity (r² > 0.993), enrichment factors (820–1070), limits of detection (2–4 ng mL^?1) and quantification (8–12 ng mL^?1), and relative standard deviations (3–6%) for both intraday and interday precisions (concentration = 50 ng mL^?1) were satisfactory for determination of the selected antidepressants. Finally the method was successfully applied to determine the target pharmaceuticals in urine. Copyright © 2014 John Wiley & Sons, Ltd.     

Optimisation of an in-tube solid phase microextraction method coupled with HPLC for determination of some oestrogens in environmental liquid samples using different capillary columns

A simple on-line method for simultaneous determination of some oestrogens including oestriol (E3), norethisterone (NORE), ethynylestradiol (EE2), D-norgestrel (NORG) and bisphenol A (BPA), in environmental liquid samples was developed by coupling in-tube solid phase microextraction (in-tube SPME) to high-performance liquid chromatography with diode array (DAD) and fluorescence (FLD) detectors. Two capillary chromatographic columns (Supel-Q? and Carboxen? 1006 porous layer open tubular) were selected to develop this method. To achieve optimum extraction performance, several parameters were investigated including number of draw/eject cycles and the sample volume for each of the columns. Reproducibility was satisfactory for inter- and intra-day precision, yielding % RSDs of less than 10% and 7.6%, respectively. Limits of detection (LODs) and quantification (LOQs) for the proposed method using a DAD detector were achieved in the ranges of 0.04–0.63?ng?mL^?1 and 0.12–1.9?ng?mL^?1, depending of the capillary column used. Fluorescence detection improved these parameters for E3, BPA and EE2, obtaining LODs of 0.005–0.03?ng?mL^?1 and LOQs of 0.015–0.08?ng?mL^?1 using Supel-Q and LODs of 0.01–0.015?ng?mL^?1 and LOQs of 0.025–0.04?ng?mL^?1 using Carboxen. The proposed method was successfully applied to spiked environmental waters obtaining recoveries greater than 80%.     

Determination of Buspirone and its Metabolite 1-(2-Pyrimidinyl)-Piperazine in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry

A sensitive, robust and high throughput mass spectrometry based method is described for the determination of buspirone and its active metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in human plasma. The method uses Oasis MCX solid phase extraction to extract the analytes from plasma. The extracts are analysed by liquid chromatography tandem mass spectrometry using thermally and pneumatically assisted electrospray ionisation and selected reaction monitoring. The method is both accurate and precise with both intra- and inter-assay precision (%CV) of <10% for both buspirone and 1-PP. The method provides a lower limit of quantification of 0.025 ng mL^?1 and 0.5 ng mL^?1 for buspirone and 1-PP respectively from 0.5 mL of human plasma, sufficient to monitor systemic concentrations of drug and active metabolite at therapeutic doses.     

Analysis of dextromethorphan and pseudoephedrine in human plasma and urine samples using hollow fiber-based liquid–liquid–liquid microextraction and corona discharge ion mobility spectrometry

We report on the use of hollow fiber liquid-liquid-liquid microextraction (HF-LLLME) followed by corona discharge ion mobility spectrometry for the determination of dextromethorphan and pseudoephedrine in urine and plasma samples. The effects of pH of the donor phase, stirring rate, ionic strength and extraction time on HF-LLLME were optimized. Under the optimized conditions, the linear range of the calibration curves for dextromethorphan in plasma and urine, respectively, are from 1.5 to 150 and from 1 to 100 ng mL^?1. The ranges for pseudoephedrine, in turn, are from 30 to 300 and from 20 to 200 ng mL^?1. Correlation coefficients are better than 0.9903. The limits of detection are 0.6 and 0.3 ng mL^?1 for dextromethorphan, and 8.6 and 4.2 ng mL^?1 for pseudoephedrine in plasma and urine samples, respectively. The relative standard deviations range from 6 to 8%.

Highly Selective Adsorptive Cathodic Stripping Voltammetric Determination of Uranium in the Presence of Pyromellitic Acid

A very sensitive and selective adsorptive cathodic stripping procedure for trace measurement of uranium is presented. The method is based on adsorptive accumulation of the uranium‐pyromellitic acid (benzene‐1,2,4,5‐tetracarboxylic acid) complex onto a hanging mercury drop electrode, followed by reduction of the adsorbed species by voltammetric scan using differential pulse modulation. Influences of effective parameters such as pH, concentration of pyromellitic acid, accumulation potential and accumulation time on the sensitivity were studied. The peak current was proportional to the concentration of U(IV) up to 40 ng mL^?1 with a limit of detection of 0.136 ng mL^?1 with an accumulation time of 120 s. The range of linearity enhanced to 71.4 ng mL^?1and the detection limit improved to 0.058 ng mL^?1with accumulation times of 60 s and 300 s respectively. The relative standard deviation for 10 replicate determination of 4.76 ng mL^?1 U(IV) was equal to 2.7%. The possible interference by major cations and anions are investigated. The method was applied to the determination of uranium in some analytical grade salts, seawater and in synthetic samples corresponding to some uranium alloys with satisfactory results.     

Quantification of Clenbuterol in Human Plasma and Urine by Liquid Chromatography-Tandem Mass Spectrometry

The quantitative determination of clenbuterol in human plasma and urine is of particular interest for various fields such as clinical and forensic research and doping controls. A simple and rapid sample preparation procedure based on liquid-liquid extraction with subsequent re-extraction followed by liquid chromatography and electrospray ionization tandem mass spectrometry allowed the determination of clenbuterol in urine and plasma at detection and quantification limits of 0.1 ng mL⁻¹ and 0.2 ng mL⁻¹, respectively, with recoveries ranging from 85–96%. The fast and robust nature of the assay provides a rapid and cost-effective alternative to established procedures utilizing solid-phase extraction strategies.     

New method for microextraction of ultra trace quantities of gold in real samples using ultrasound-assisted emulsification of solidified floating organic drops

A method was developed for the determination of gold ion in water samples using microextraction based on the ultrasound-assisted emulsification of solidified floating organic drops, followed by the flame atomic absorption spectrometry. N-(4-{4-[(anilinocarbothioyl)amino]benzyl}phenyl)-N-phenylthiourea was used as chelating agent. The parameters affecting the extraction and complex formation (including the type and volume of the extracting solvent, time of sonication and centrifugation, pH, amount of the chelating agent, and sample ionic strength) were optimized. Under the optimum conditions, the calibration graph is linear in the range from 1.5 to 400 ng mL^?1, with a limit of detection of 0.45 ng mL^?1. The relative standard deviation for ten replicate determinations of gold ion in a concentration of 175 ng mL^?1 was 1.7%. The procedure was successfully applied to the determination of gold in water samples, in pharmaceutical and synthetic samples, and in a standard reference material.